- Home
- LSBPW vs CTRN Comparison
LSBPW vs CTRN Comparison
Compare LSBPW & CTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSBPW
- CTRN
- Stock Information
- Founded
- LSBPW N/A
- CTRN 1946
- Country
- LSBPW China
- CTRN United States
- Employees
- LSBPW 758
- CTRN N/A
- Industry
- LSBPW Biotechnology: Pharmaceutical Preparations
- CTRN Clothing/Shoe/Accessory Stores
- Sector
- LSBPW Health Care
- CTRN Consumer Discretionary
- Exchange
- LSBPW Nasdaq
- CTRN Nasdaq
- Market Cap
- LSBPW N/A
- CTRN N/A
- IPO Year
- LSBPW N/A
- CTRN 2005
- Fundamental
- Price
- LSBPW $0.05
- CTRN $25.23
- Analyst Decision
- LSBPW
- CTRN Strong Buy
- Analyst Count
- LSBPW 0
- CTRN 3
- Target Price
- LSBPW N/A
- CTRN $27.67
- AVG Volume (30 Days)
- LSBPW N/A
- CTRN 121.2K
- Earning Date
- LSBPW N/A
- CTRN 12-03-2024
- Dividend Yield
- LSBPW N/A
- CTRN N/A
- EPS Growth
- LSBPW N/A
- CTRN N/A
- EPS
- LSBPW N/A
- CTRN N/A
- Revenue
- LSBPW N/A
- CTRN $757,086,000.00
- Revenue This Year
- LSBPW N/A
- CTRN $1.35
- Revenue Next Year
- LSBPW N/A
- CTRN $2.77
- P/E Ratio
- LSBPW N/A
- CTRN N/A
- Revenue Growth
- LSBPW N/A
- CTRN 2.00
- 52 Week Low
- LSBPW N/A
- CTRN $13.66
- 52 Week High
- LSBPW N/A
- CTRN $32.90
- Technical
- Relative Strength Index (RSI)
- LSBPW N/A
- CTRN 62.50
- Support Level
- LSBPW N/A
- CTRN $24.10
- Resistance Level
- LSBPW N/A
- CTRN $27.05
- Average True Range (ATR)
- LSBPW 0.00
- CTRN 1.50
- MACD
- LSBPW 0.00
- CTRN -0.01
- Stochastic Oscillator
- LSBPW 0.00
- CTRN 62.16
About LSBPW LakeShore Biopharma Co. Ltd
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.